Sanara MedTech Statistics
Share Statistics
Sanara MedTech has 8.74M shares outstanding. The number of shares has increased by 2.44% in one year.
| Shares Outstanding | 8.74M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.41% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.03M |
| Failed to Deliver (FTD) Shares | 3 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 202.97K, so 2.32% of the outstanding shares have been sold short.
| Short Interest | 202.97K |
| Short % of Shares Out | 2.32% |
| Short % of Float | 6.7% |
| Short Ratio (days to cover) | 7.49 |
Valuation Ratios
The PE ratio is -79.07 and the forward PE ratio is -30.56.
| PE Ratio | -79.07 |
| Forward PE | -30.56 |
| PS Ratio | 5.24 |
| Forward PS | 3.1 |
| PB Ratio | 7.59 |
| P/FCF Ratio | -96.92 |
| PEG Ratio | n/a |
Enterprise Valuation
Sanara MedTech Inc. has an Enterprise Value (EV) of 346.91M.
| EV / Earnings | -80.62 |
| EV / Sales | 5.34 |
| EV / EBITDA | -1199.98 |
| EV / EBIT | -82.3 |
| EV / FCF | -98.81 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.22.
| Current Ratio | 1.38 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.22 |
| Total Debt / Capitalization | 18.32 |
| Cash Flow / Debt | -0.32 |
| Interest Coverage | -8.86 |
Financial Efficiency
Return on equity (ROE) is -0.1% and return on capital (ROIC) is -7.48%.
| Return on Equity (ROE) | -0.1% |
| Return on Assets (ROA) | -0.06% |
| Return on Capital (ROIC) | -7.48% |
| Revenue Per Employee | 607.38K |
| Profits Per Employee | -40.22K |
| Employee Count | 107 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 1.66 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -7.55% in the last 52 weeks. The beta is 1.56, so Sanara MedTech 's price volatility has been higher than the market average.
| Beta | 1.56 |
| 52-Week Price Change | -7.55% |
| 50-Day Moving Average | 34.18 |
| 200-Day Moving Average | 32.61 |
| Relative Strength Index (RSI) | 51.03 |
| Average Volume (20 Days) | 30.14K |
Income Statement
In the last 12 months, Sanara MedTech had revenue of $64.99M and earned -$4.30M in profits. Earnings per share was $-0.52.
| Revenue | 64.99M |
| Gross Profit | 57.14M |
| Operating Income | -4.22M |
| Net Income | -4.30M |
| EBITDA | -289.10K |
| EBIT | -4.22M |
| Earnings Per Share (EPS) | -0.52 |
Balance Sheet
The company has $5.15M in cash and $11.79M in debt, giving a net cash position of -$6.64M.
| Cash & Cash Equivalents | 5.15M |
| Total Debt | 11.79M |
| Net Cash | -6.64M |
| Retained Earnings | -28.04M |
| Total Assets | 88.55M |
| Working Capital | 17.57M |
Cash Flow
In the last 12 months, operating cash flow was -$3.25M and capital expenditures -$265.25K, giving a free cash flow of -$3.51M.
| Operating Cash Flow | -3.25M |
| Capital Expenditures | -265.25K |
| Free Cash Flow | -3.51M |
| FCF Per Share | -0.42 |
Margins
Gross margin is 87.92%, with operating and profit margins of -6.49% and -6.62%.
| Gross Margin | 87.92% |
| Operating Margin | -6.49% |
| Pretax Margin | -6.83% |
| Profit Margin | -6.62% |
| EBITDA Margin | -0.44% |
| EBIT Margin | -6.49% |
| FCF Margin | -5.4% |
Dividends & Yields
SMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -1.5% |
| FCF Yield | -1.16% |
Analyst Forecast
The average price target for SMTI is $44, which is 26.9% higher than the current price. The consensus rating is "Buy".
| Price Target | $44 |
| Price Target Difference | 26.9% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
Stock Splits
The last stock split was on May 10, 2019. It was a backward split with a ratio of 1:100.
| Last Split Date | May 10, 2019 |
| Split Type | backward |
| Split Ratio | 1:100 |
Scores
| Altman Z-Score | 4.06 |
| Piotroski F-Score | 4 |